The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors
Open accessAbstract
There is evidence of derangement of oxidant and antioxidant defense systems in depression. The present study examined the effects of fluoxetine and citalopram, standard selective serotonin re-uptake inhibitors, on lipid peroxidation, superoxide dismutase (SOD) activity and ascorbic acid concentrations. For this, a prospective open-labeled, randomized design was utilized. Patients with major depression (n = 62) were compared with age- and sex-matched healthy volunteers (n = 40). There was a significant increase in serum SOD, serum MDA and decrease in plasma ascorbic acid levels in patients of major depression as compared to control subjects. The trend reversed significantly after treatment with fluoxetine and citalopram. Results indicate a greater reduction in oxidative stress with citalopram than fluoxetine. The Hamilton Rating Scale for Depression (HRSD) score also improved with fluoxetine and citalopram treatment. These findings indicate that major depression is associated with increased levels of serum SOD, serum MDA and decreased levels of plasma ascorbic acid. Treatment with fluoxetine and citalopram reversed these biochemical parameters. This study can be used as a predictor of drug response by fluoxetine and citalopram in major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Khanzode and colleagues reported that SSRIs reduced serum levels of malondialdehyde and increased plasma ascorbic acid levels, which correlated with improvements on the Hamilton Depression Rating Scale (107).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [107]
Experimental — accuracy not yet measuredIn the citing paper
“or a significant increase in most of the studies [123, 124, 128, 129].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [128]
In the citing paper
“In another study, plasmatic vitC levels were reduced in patients with MDD compared with age- and sex-matched healthy volunteers (n = 40).”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [27]
In the citing paper
“Oxidative stress markers (SOD, vitC, lipid peroxidation) were reversed after 4 weeks of treatment with fluoxetine (20 mg/day, n = 32) and citalopram (20 mg/day, n = 30).”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [27]
In the citing paper
“Notably, these antioxidant effects were persistent after 12 weeks of treatment [27].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [27]
In the citing paper
“Increased serum SOD and MDA levels have been found in a cohort of 62 major depressive patients (age 43.8 ± 12.9, mean ± SD; 34/28, female/male ratio) [27].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
Superoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method
Kei, S. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90081-5 · Cited by 1,730
Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method
佐藤, 敬. (1979) · Medical Entomology and Zoology · Cited by 1,520
Superoxide Radical: An Endogenous Toxicant
Fridovich, I. (1983) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.23.040183.001323 · Cited by 1,168
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy
Hibbeln, J. R., & Salem, N. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.1 · Cited by 525
Maes, M. H. J., Christophe, A. B., Delanghe, J., Altamura, C. A., Neels, H. M., & Meltzer, H. Y. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00014-1 · Cited by 452
Ambrosone, C. B., Freudenheim, J. L., Thompson, P. A., Bowman, E. D., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., & Shields, P. G. (1999) · PubMed · Cited by 400
Research works printed but not linked: 12
- Ravikumar A, 2000, Indian J Exp Biol, 38, 438
- Bilici M, 2001, J Affect Disord, 88, 69
- Cohen G, 1984, Neurotoxicology, 5, 77
- Stocks J, 1974, Clin Sci Mol Med, 47, 215
- Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and mania. In: Molinoff PB, Ruddon RW. (eds) Goodman and Gilman 's - The Pharmacological Basis of Therapeutics. 10th edn. New York: McGraw-Hill, 2000; 447-480.
- Nischal HK, 1998, J Assoc Physicians India, 46, 853
- Shigennobu UMS, 1987, Clin Chem, 31, 2230
- Ambrosone CB, 1999, Cancer Res, 59, 602
- Sen CK, 1995, Indian J Physiol Pharmacol, 39, 177
- Sen CK, 1994, Physiological antioxidants, 89
- Li XM, 2000, J Psychiatr Neurosci, 25, 43
- Bezchlibnyk K, 2000, J Psychiatr Neurosci, 25, 241
Cited by
Sorted by citations
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders
Mattson, M. P., Maudsley, S., & Martin, B. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.001 · Cited by 942
Role of oxidative stress in depression
Bhatt, S., Nagappa, A. N., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.001 · Cited by 854
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.014 · Cited by 724
Comorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Maes, M. H. J., Kubera, M., & Leunis, J. (2008) · PubMed · Cited by 609
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Therefore, modulation of NO signaling is a potential therapeutic target for MDD. Nagele and colleagues found that inhaled N2O at a concentration of either 25% or 50% significantly reduced scores on the Hamilton Depression Rating Scale (HDRS) at week 2 in patients with treatment resistant depression.”
BackgroundSarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Impaired mitochondrial function in psychiatric disorders
Manji, H. K., Kato, T., Prospero, N. A. D., Ness, S. L., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3229 · Cited by 491
Wolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421
Oxidative & nitrosative stress in depression: Why so much stress?
Moylan, S., Berk, M., Dean, O. M., Samuni, Y., Williams, L. J., O'Neil, A. E., Hayley, A. C., Pasco, J. A., Anderson, G., Jacka, F. N., et al. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.007 · Cited by 412
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
Berk, M., Dean, O. M., Drexhage, H. A., McNeil, J. J., Moylan, S., O'Neil, A. E., Davey, C. G., Sanna, L., & Maes, M. H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-74 · Cited by 395
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Markers of Oxidative Stress and Neuroprogression in Depression Disorder
Vaváková, M., Ďuračková, Z., & Trebatická, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/898393 · Cited by 324
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R. C., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 314
Depression gets old fast: do stress and depression accelerate cell aging?
Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298
Fruit and vegetable consumption and the risk of depression: A meta-analysis
Liu, X., Yan, Y., Li, F., & Zhang, D. (2015) · Nutrition · doi:10.1016/j.nut.2015.09.009 · Cited by 287
Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies
Palta, P., Samuel, L. J., Miller, E. R., & Szanton, S. L. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000009 · Cited by 277
Mattson, M. P., Maudsley, S. R., & Martin, B. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.08.001 · Cited by 271
Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism
Kern, J. K., & Jones, A. M. (2006) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400600882079 · Cited by 265
Dysregulated relationship of inflammation and oxidative stress in major depression
Rawdin, B. J., Mellon, S. H., Dhabhar, F. S., Epel, E. S., Puterman, E., Su, Y., Burke, H. M., Reus, V. I., Rosser, R., Hamilton, S. P., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.11.011 · Cited by 255
Wang, X., Li, P., Ding, Q., Wu, C., Zhang, W., & Tang, B. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11414 · Cited by 254
Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
Omega-3 fatty acids and neuropsychiatric disorders
Young, G. S., & Conquer, J. A. (2005) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:2005001 · Cited by 257
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248
Ageing and neurodegenerative diseases
Hung, C.-W., Chen, Y., Hsieh, W.-L., Chiou, S., & Kao, C.-L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.006 · Cited by 257
Juszczyk, G., Mikulska, J., Kasperek, K., Pietrzak, D., Mrozek, W., & Herbet, M. (2021) · Antioxidants · doi:10.3390/antiox10091439 · Cited by 246
Tobacco smoking as a risk factor for major depressive disorder: population-based study
Pasco, J. A., Williams, L. J., Jacka, F. N., Ng, F., Henry, M. J., Nicholson, G. C., Kotowicz, M. A., & Berk, M. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046706 · Cited by 233
Antioxidants as potential therapeutics for neuropsychiatric disorders
Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70084-2 · Cited by 214
Hou, J., Yu, K., Sunwoo, K., Kim, W. Y., Koo, S., Wang, J., Ren, W. X., Wang, S., Yu, X., & Kim, J. S. (2020) · Chem · doi:10.1016/j.chempr.2019.12.005 · Cited by 214
Moretti, M., Colla, A. R. D. S., Balen, G. O., Santos, D. B., Budni, J., Freitas, A. E., Farina, M., & Rodrigues, A. L. S. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.009 · Cited by 211
Maes, M. H. J., Kubera, M., Leunis, J., Berk, M., Geffard, M., & Bosmans, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01908.x · Cited by 209
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
Antioxidative enzymes and increased oxidative stress in depressive women
Kodydková, J., Vávrová, L., Zeman, M., Jirák, R., Macášek, J., Staňková, B., Tvrzická, E., & Žák, A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.006 · Cited by 197
Kodl, C. T., Franc, D. T., Rao, J. P., Anderson, F. S., Thomas, W. T. B., Mueller, B. A., Lim, K. O., & Seaquist, E. R. (2008) · Diabetes · doi:10.2337/db08-0724 · Cited by 191
de Melo, Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Gałecki, P., Carvalho, A. F., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 194
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 191
Zhao, Z., Wang, W., Guo, H., & Zhou, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.030 · Cited by 187
Brocardo, P. S., Boehme, F., Patten, A., Cox, A., Gil-Mohapel, J., & Christie, B. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.006 · Cited by 186
Antioxidants as Antidepressants
Scapagnini, G., Davinelli, S., Drago, F., LORENZO, A. D., & Oriani, G. (2012) · CNS Drugs · doi:10.2165/11633190-000000000-00000 · Cited by 188
In vivo antioxidant status: A putative target of antidepressant action
Zafir, A., Ara, A., & Banu, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.010 · Cited by 183
The relevance of oxidative stress status in first episode and recurrent depression
Stefanescu, C., & Ciobica, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.022 · Cited by 179
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165
Du, J., Zhu, M. F., Bao, H., Bai, L., Dong, Y., Xiao, C., Zhang, G. Y., Henter, I. D., Rudorfer, M. V., & Vitiello, B. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.876960 · Cited by 164
Altered expression of neurotrophic factors in patients with major depression
Otsuki, K., Uchida, S., Watanuki, T., Wakabayashi, Y., Fujimoto, M., Matsubara, T., Funato, H., & Watanabe, Y. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.01.010 · Cited by 163
da Silva, L. A., Tortelli, L., Motta, J. V. D. S., Menguer, L., Mariano, S., Tasca, G. M., Silveira, G. D. B., Pinho, R. A., & Silveira, P. C. L. (2019) · Clinics · doi:10.6061/clinics/2019/e322 · Cited by 161
Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link
Korczak, D. J., Pereira, S., Koulajian, K., Matejcek, A., & Giacca, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2240-3 · Cited by 163
Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112458732 · Cited by 151
Kotan, V. O., Sarandol, E., Kirhan, E., Ozkaya, G., & Kirli, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.021 · Cited by 149
Binfaré, R. W., Rosa, A. O., Lobato, K. R., Santos, A. R. S., & Rodrigues, A. L. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.003 · Cited by 150
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Anderson, G., & Maes, M. H. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 148
The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder
Vieta, E., Popović, D., Rosa, A. R., Solé, B., Grande, I., Frey, B. N., Martínez‐Arán, A., Sánchez‐Moreno, J., Balanzá‐Martínez, V., Tabarés‐Seisdedos, R., et al. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.007 · Cited by 149
Rybka, J., Kędziora-Kornatowska, K., Banaś-Leżańska, P., Majsterek, I., Carvalho, L. A., Cattaneo, A., Anacker, C., & Kędziora, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.019 · Cited by 146
Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants
Lee, S., Lee, S.-J., Han, C., Patkar, A. A., Masand, P. S., & Pae, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.008 · Cited by 148
Vollbracht, C., Schneider, B., Leendert, V., Weiß, G., Auerbach, L., & Beuth, J. (2011) · PubMed · Cited by 145
Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.014 · Cited by 147
Oxidative stress markers in affective disorders
Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71517-2 · Cited by 142
Pomara, N., Bruno, D., Sarreal, A. S., Hernando, R. T., Nierenberg, J. J., Petkova, E., Sidtis, J. J., Wısnıewskı, T., Mehta, P. D., Praticò, D., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11081153 · Cited by 142
Omega-3 fatty acids and major depression: A primer for the mental health professional
Logan, A. C. (2004) · Lipids in Health and Disease · doi:10.1186/1476-511x-3-25 · Cited by 142
Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
Xu, Y., Wang, C., Klabnik, J., & Donnell, J. O. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120231448 · Cited by 141
Arora, V. K., Kuhad, A., Tiwari, V., & Chopra, K. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.04.012 · Cited by 138
Nrf2: An all-rounder in depression
Zuo, C., Cao, H., Song, Y., Gu, Z., Huang, Y., Yang, Y., Miao, J., Zhu, L., Chen, J., Jiang, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102522 · Cited by 139
Medical comorbidity in bipolar disorder: reprioritizing unmet needs
McIntyre, R. S., Soczynska, J. K., Beyer, J. L., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Konarski, J. Z., & Kennedy, S. H. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281938102 · Cited by 138
Salehpour, F., Farajdokht, F., Cassano, P., Sadigh‐Eteghad, S., Erfani, M., Hamblin, M. R., Salimi, M. M., Karimi, P., Rasta, S. H., & Mahmoudi, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.010 · Cited by 138
Szuster‐Ciesielska, A., Słotwińska, M., Stachura, A., Marmurowska-Michałowska, H., Dubas-Ślemp, H., Bojarska-Junak, A. A., & Kandefer‐Szerszeń, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.11.012 · Cited by 135
The role of vitamin C in stress-related disorders
Moritz, B., Schmitz, A. E., Rodrigues, A. L. S., Dafré, A. L., & Cunha, M. P. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108459 · Cited by 138
Minocycline: Therapeutic Potential in Psychiatry
Dean, O. M., Data-Franco, J., Giorlando, F., & Berk, M. (2012) · CNS Drugs · doi:10.2165/11632000-000000000-00000 · Cited by 131
Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study
Flensborg‐Madsen, T., von Scholten, M. B., Flachs, E. M., Mortensen, E. L., Prescott, E., & Tolstrup, J. S. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.06.006 · Cited by 131
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1014 · Cited by 124
Antidepressant activity of Asparagus racemosus in rodent models
Singh, G. K., Garabadu, D., Muruganandam, A. V., Joshi, V. K., & Krishnamurthy, S. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.010 · Cited by 122
Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants
Tsuboi, H., Tatsumi, A., Yamamoto, K., Kobayashi, F., Shimoi, K., & Kinae, N. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.010 · Cited by 119
Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression
Dimopoulos, N., Piperi, C., Psarra, V., Lea, R. W., & Kalofoutis, A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.019 · Cited by 118
Chiu, C., Chyau, C.-C., Chen, C., Lee, L., Chen, W.-P., Liu, J.-L., Lin, W., & Mong, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020341 · Cited by 122
Increased xanthine oxidase in the thalamus and putamen in depression
Michel, T. M., Camara, S., Tatschner, T., Frangou, S., Sheldrick, A. J., Riederer, P., & Grünblatt, E. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802123695 · Cited by 114
Kubera, M., Curzytek, K., Duda, W., Leśkiewicz, M., Basta‐Kaim, A., Budziszewska, B., Roman, A., Zajı́cová, A., Holáň, V., Szczęsny-Małysiak, E., et al. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.01.001 · Cited by 119
Anti‐inflammatory, antiapoptotic, and antioxidant activity of fluoxetine
Caiaffo, V., de Oliveira, B. D. R., de Sá, F. B., & Evêncio‐Neto, J. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.231 · Cited by 112
Dietary selenium and major depression: a nested case-control study
Pasco, J. A., Jacka, F. N., Williams, L. J., Evans-Cleverdon, M., Brennan-Olsen, S. L., Kotowicz, M. A., Nicholson, G. C., Ball, M. J., & Berk, M. (2012) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2011.12.008 · Cited by 112
de Morais, H., de Souza, C. P., da Silva, L. M., Ferreira, D. M., Werner, M. F., Andreatini, R., da Cunha, J. M., & Zanoveli, J. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.011 · Cited by 111
Zhang, Y., Wang, X., Bai, X., Li, P., Su, D., Zhang, W., Zhang, W., & Tang, B. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01878 · Cited by 107
Wang, X., Li, P., Ding, Q., Wu, C., Zhang, W., & Tang, B. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901318 · Cited by 106
Sowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R. J., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.024 · Cited by 104
Serum uric acid levels and the clinical characteristics of depression
Wen, S., Cheng, M., Wang, H., Yue, J., Wang, H., Li, G., Zheng, L., Zhong, Z., & Peng, F. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.010 · Cited by 104
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“In fact, in MDD, while most of the authors have generally described decreased levels of GPX and increased levels of malondialdehyde (MDA), as a lipid peroxidation marker [123, 126], there are also controversies regarding the specific activity of some antioxidant enzymes such as SOD,whichwas reported to be decreased in…”
ResultMaes, M., Landucci Bonifacio, K., Morelli, N. R., Vargas, H. O., Barbosa, D. S., Carvalho, A. F., & Nunes, S. O. V. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1051-7 · Cited by 102
Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?
Trebatická, J., & Ďuračková, Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/248529 · Cited by 104
Antioxidant and Anti-Inflammatory Effects of Carotenoids in Mood Disorders: An Overview
Rasmus, P., & Kozłowska, E. (2023) · Antioxidants · doi:10.3390/antiox12030676 · Cited by 102
Amr, M., El-Mogy, A., Shams, T., Vieira, K. F., & Lakhan, S. E. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-31 · Cited by 103
Tayeb, A. E. K. A., Poinsignon, V., Chappell, K., Bouligand, J., Becquemont, L., & Verstuyft, C. (2023) · Antioxidants · doi:10.3390/antiox12040942 · Cited by 100
Aboul-Fotouh, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.027 · Cited by 97
The Association between Conventional Antidepressants and the Metabolic Syndrome
McIntyre, R. S., Park, K. Y., Law, C. W. Y., Sultan, F., Adams, A., Lourenço, M. T. C., Lo, A., Soczynska, J. K., Woldeyohannes, H. O., Alsuwaidan, M. T., et al. (2010) · CNS Drugs · doi:10.2165/11533280-000000000-00000 · Cited by 98
Metadata
- Authors
- Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R.
- Affiliations
- Government Medical College (IN)
- ORCID
- Dakhale, Ganesh N.
- Venue
- Redox Report
- Publisher
- Informa UK Limited
- Published
- 2003-12
- Volume
- 8
- Issue
- 6
- Pages
- 365-370
- ISSN
- 1351-0002 (ISSN-L)
- 1743-2928
- OpenAlex
- W2090999800
- Cited by
- 458
- References
- 27
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 24 · 2023: 14 · 2022: 27 · 2021: 19 · 2020: 24 · 2019: 25 · 2018: 29 · 2017: 23 · 2016: 25 · 2015: 29 · 2014: 35 · 2013: 29 · 2012: 30
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Redox Report (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, oxidative stress, selective serotonin reuptake inhibitors, fluoxetine, citalopram, lipid peroxidation, malondialdehyde, superoxide dismutase, vitamin C, antioxidant defense, antidepressant response prediction
- MeSH terms
- Adult, Antioxidants, Ascorbic Acid, Depression, Female, Fluoxetine, Humans, Male, Malondialdehyde, Middle Aged, Prospective Studies, Superoxide Dismutase, Time Factors, Lipid Peroxidation, Citalopram, Selective Serotonin Reuptake Inhibitors, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review